Abacavir
- Product NDC
- 72865-167
- 11-digit product format
- 728650167
- Labeler code
- 72865
- Product ID
- 72865-167_f26efe20-afb4-390a-e053-2a95a90ae396
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- XLCare Pharmaceuticals Inc.
- Application
- ANDA091560
- Marketing category
- ANDA
- Marketing start
- 2021-05-28
- Substance
- ABACAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Abacavir
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ABACAVIR SULFATE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J220T4J9Q2 |
| Rxcui | 242679 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72865-167-60 | Abacavir | 60 in 1 BOTTLE | TABLET | 60 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72865-167 | ABACAVIR (ABACAVIR) TABLET [XLCARE PHARMACEUTICALS INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20230117_633f1ec9-53b1-4a9a-a738-8cae5b763f08.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72865-167-60 | 72865016760 | 60 TABLET in 1 BOTTLE (72865-167-60) | 60 tablet | 2021-05-28 | 0000-00-00 | No | No | Current |